Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-201-9 | CAS number: 135-57-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: dermal
Administrative data
- Endpoint:
- sub-chronic toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- OECD Guideline for Testing of Chemicals No. 410. Repeated Dose Dermal Toxicity:21/28-Day,1-8. May. 1981 State Environmental Protection Administration : The Guidelines for the Testing of Chemicals Ministry of Health,2005: Technical standards for testing of chemicals .
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 410 (Repeated Dose Dermal Toxicity: 21/28-Day Study)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: State Environmental Protection Administration : The Guidelines for the Testing of Chemicals
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: Ministry of Health,2005: Technical standards for testing of chemicals .
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- yes
Test material
- Reference substance name:
- N,N'-dithiodi-o-phenylenedibenzamide
- EC Number:
- 205-201-9
- EC Name:
- N,N'-dithiodi-o-phenylenedibenzamide
- Cas Number:
- 135-57-9
- Molecular formula:
- C26H20N2O2S2
- IUPAC Name:
- N-{2-[(2-benzamidophenyl)disulfanyl]phenyl}benzamide
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Test species: Rats.
Strain: SD.
Supplier: Guangdong Medical Laboratory Animal Center [certified animal number SCXK (Guangdong) 2008-0002].
Number of animals: 25 males and 25 females.
Number of groups: 5(control group, Low-dose group, Intermediate-dose group, High-dose group and Additional group of high-dose).
Number of animal/group: 5 males and 5 females per group.
Body weight at the start of experiment: 200 ~ 274g .
Identification of animals: Tags marked with animal group number and treatment details were attached to cages. Each animal was given an unique number.
Acclimatization: Five days prior to the experiment in the test room.
Randomization: Animals were assigned to five groups randomly.
Environmental conditions
Test Room: In the Center
Animal house conditions: The test facility was an air-conditioned room with 12h artificial fluorescent light and 12h dark.
Temperature range: 20~25oC.
Humidity range: 40~70%.
Husbandry Practices
Caging: Stainless steel cages were used. Autoclaved clean dry corncob was used as the bedding material. Animals were housed in one group according to sex in cages.
Water bottle: Each cage was supplied with a polypropylene water bottle with a stainless steel nozzle.
Sanitation: Bedding material was changed daily.
Food and water: Standard pellet feed supplied by Guangdong Medical Laboratory Animal Center and ultra-pure filtered sterilized water were provided to the animals freely.
Frequency of providing feed and drinking water: Both drinking water and feed were provided ad libitum.
Administration / exposure
- Type of coverage:
- open
- Vehicle:
- water
- Details on exposure:
- Healthy young adult animals are acclimatized to the laboratory conditions for 5 days prior to the test. Before the test, animals are randomized and assigned to the treatment and control groups. An area of about 5×8 cm2 on the back of the animal was clipped free of hair. Repeat clipping or shaving is usually needed at approximately weekly intervals. Pepton 22 was administered on the hair-free site of the rats for 6 hours per day on a 5-day per week basis, for a period of 28 days. The rats were fasten in the stainless steel shelves for 6h, then the test site were cleaned with warm water every time. Animals of the Low-dose group were conducted in the 40 mg/kg dose level, the Intermediate-dose group were conducted in the 200 mg/kg dose level, the High-dose group were conducted in the 800 mg/kg dose level, the Additional group of high-dose were conducted in the 800 mg/kg dose level too, the control group were given distilled water instead of tested compounds, with the same procedure as all the test groups.
- Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- 28 days
- Frequency of treatment:
- Pepton 22 was administered on the hair-free site of the rats for 6 hours per day on a 5-day per week basis, for a period of 28 days.
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
Low-dose group: 40 mg/kg
Basis:
nominal per unit body weight
- Remarks:
- Doses / Concentrations:
Medium-dose group: 200 mg/kg
Basis:
nominal per unit body weight
- Remarks:
- Doses / Concentrations:
High-dose group: 800 mg/kg
Basis:
nominal per unit body weight
- Remarks:
- Doses / Concentrations:
High-dose group (additional): 800 mg/kg
Basis:
nominal per unit body weight
- No. of animals per sex per dose:
- 5 males and 5 females per group
25 males and 25 females in total - Control animals:
- yes, concurrent vehicle
- Details on study design:
- Healthy young adult animals were acclimatized to the laboratory conditions for 5 days prior to the test. Before the test, animals are randomized and assigned to the treatment and control groups. An area of about 5×8 cm2 on the back of the animal was clipped free of hair. Repeat clipping or shaving were usually needed at approximately weekly intervals. Pepton 22 was administered on the hair-free site of the rats for 6 hours per day on a 5-day per week basis, for a period of 28 days. The rats were fasten in the stainless steel shelves for 6h, then the test site were cleaned with warm water every time. Animals of the Low-dose group were conducted at the 40 mg/kg dose level, the Medium-dose group were conducted at the 200 mg/kg dose level, the High-dose group were conducted at the 800 mg/kg dose level, the Additional high-dose group were conducted at the 800 mg/kg dose level too, the Control group were given distilled water instead of tested compounds, with the same procedure as all the test groups.
- Positive control:
- The Control group was given distilled water instead of tested compounds, using the same procedure as all the test groups.
Examinations
- Observations and examinations performed and frequency:
- Observation period: All animals were observed signs of toxicity, including the time of onset the degree and duration, everyday for a period of 28 days, but animals of Additional high-dose group scheduled for follow-up observations were kept for a further 14 days without treatment to detect recovery from, or persistence of, toxic effects.
Observation: A careful clinical examination was made once each day. Additional observations was made daily with appropriate actions taken to minimize loss of animals to the study. Necropsy or refrigeration of those animals found dead and isolation or sacrifice of weak or moribund animals.
Body weight: Body weight of each animal was recorded weekly and before necropsy.
Hematology test: Including erythrocyte count, hematocrit, hemoglobin concentration, platelet count, total and differential leucocyte count, thromboplastin time and partial thromboplastin time were investigated at the end of the test period.
Biochemistry test: Clinical biochemistry determination on blood was carried out at the end of the test period. Blood parameters of liver and kidney function are appropriate. The selection of specific tests was influenced by observations on the mode of action of the substance.
Include serum glutamic-pyruvic transaminase(ALT), serum glutamic-oxaloacetic transaminase(AST), gamma glutamyl transpeptidase(GGT), total bilirubin(TB), total serum protein(TP), albumen(ALB), blood creatinine(CRE) and urea nitrogen(BUN) measurements.
Gross necropsy: All animals in the study were subjected to a full gross necropsy which included examination of the external surface of the body, all orifices, and the cranial, thoracic and abdominal cavities and their contents. The liver, kidneys, adrenals and testes were weighed wet as soon as possible after dissection to avoid drying.
The following organs and tissues were preserved in a suitable medium for possible future histopathological examination: normal and treated skin, brain, heart, liver, spleen, lungs, kidney, paranephroi, testis, epididymides, ovaries and uteruses.
Histopathology: Histological examination was performed with microscopy on H.E. stained slides of the preserved organs and tissues of all the tested groups and the control group. - Sacrifice and pathology:
- At the end of the experiment, all the animals were sacrificed to test some relevant indexes.
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Dermal irritation:
- not examined
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- no effects observed
- Ophthalmological findings:
- not examined
- Haematological findings:
- effects observed, treatment-related
- Description (incidence and severity):
- platelet count PLT increased (P <0.05) in males, thromboplastin time (PT) prolonged (P <0.05) in males.
- Clinical biochemistry findings:
- effects observed, treatment-related
- Description (incidence and severity):
- Biochemistry test: Compared to the result of the indexes of the Control group, there were no significant differences both in females and males in Low-, Medium-, and High-dose group. But the result of the indexes of Additional high-dose group compared with
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- no effects observed
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Description (incidence and severity):
- Compared to the result of the indexes of the Control group, there were no significant differences in females in Low-, Medium-, and High-dose group. Compared with the High-dose group, the liver coefficients and Ovaries of the Additional high-dose group wer
- Gross pathological findings:
- no effects observed
- Description (incidence and severity):
- Despite some pathological changes of the brain, cerebellum, pituitary, kidney, lung, testis and uterus of each dose group, the regularity, frequency and the degree of injury showed no significant dose-effect relationship in different dose levels. Consider
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- no effects observed
Effect levels
open allclose all
- Dose descriptor:
- NOEL
- Effect level:
- 200 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- female
- Basis for effect level:
- dermal irritation
- Dose descriptor:
- NOEL
- Effect level:
- 200 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male
- Basis for effect level:
- dermal irritation
- Dose descriptor:
- NOAEL
- Effect level:
- > 800 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- dermal irritation
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
For tables and other data, please view the full report.
Applicant's summary and conclusion
- Conclusions:
- NOAEL determined by the report assessor
>200 mg/kg/d in males
>200 mg/kg/d in females - Executive summary:
Although the Chinese test report suggests a NOAEL of 40 mg/kg/day, there is no evidence for this in the test report and minor blood parameter changes are conisdered adaptive. A NOEL of 200 mg/kg/day is suggested by the reviewer, based on adaptive changes and findings of low statistical significance. It is considered that there were no adverse effects at the highest treated group of 800 mg/kg/day.
The NOAEL is therefore estimated to be > 800 mg/kg/day.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.